DexCom Inc
(XTER:DC4)
€
78.11
5.59 (7.71%)
Market Cap: 29.79 Bil
Enterprise Value: 29.88 Bil
PE Ratio: 47.63
PB Ratio: 15.70
GF Score: 73/100 Dexcom Inc at Citi Healthcare Conference (Virtual) Transcript
Feb 23, 2022 / 03:15PM GMT
Release Date Price:
€86
(-0.32%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Thank you. Good morning, everybody. And so our next presentation today is with Jereme Sylvain from Dexcom. Jereme, thank you so much for joining us today.
Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO
Thank you, Joanne. Happy to be here, and thanks for taking time with us today.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Wonderful. I was looking up, as I was preparing for this meeting, how long you've been the CFO. And you've been in this role now for over a year, if I count correctly.
Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO
It's been about a year. So it's been an interesting year. I could -- if someone was to ask me over the course of the past year, what would you want your first year to be like? And it certainly wouldn't necessarily be during a pandemic with the great resignations, supply chain changes. But it's been a year,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot